March 12, 2024
Pliant Therapeutics
Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis
March 11, 2024
MOMA Therapeutics
MOMA Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business Officer
March 11, 2024
Synnovation Therapeutics
Synnovation Therapeutics Announces First Patient Dosed in Phase I Trial with SNV1521, a PARP1 Selective Inhibitor for the Treatment of Solid Tumors
March 05, 2024
Flare Therapeutics
Flare Therapeutics to Present Immune Profiling Data From Urothelial Cancer Patients Treated with Anti-PD1 Therapy at AACR 2024 Annual Meeting
March 05, 2024
Tango Therapeutics
Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association For Cancer Research (AACR) Annual Meeting 2024